{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:50:45Z","timestamp":1789019445311,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T00:00:00Z","timestamp":1538179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T00:00:00Z","timestamp":1538179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI119037"],"award-info":[{"award-number":["R01AI119037"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA013911"],"award-info":[{"award-number":["T32DA013911"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3396-y","type":"journal-article","created":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T02:29:39Z","timestamp":1538188179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Impact of alcohol consumption on tuberculosis treatment outcomes: a prospective longitudinal cohort study protocol"],"prefix":"10.1186","volume":"18","author":[{"given":"Bronwyn","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara C","family":"Bouton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J","family":"Ragan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura F","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McIlleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danie","family":"Theron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D H","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Robert","family":"Horsburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin M","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen R","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,29]]},"reference":[{"key":"3396_CR1","volume-title":"Geneva","author":"WHO","year":"2017","unstructured":"WHO. Global Tuberculosis Report 2017. In: Geneva; 2017."},{"key":"3396_CR2","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-9-450","volume":"9","author":"J Rehm","year":"2009","unstructured":"Rehm J, Samokhvalov AV, Neuman MG, Room R, Parry C, L\u00f6nnroth K, Patra J, Poznyak V, Popova S, Brock T, Rush B, Jacobson J, Szabo G, Rieder H, Hill A, Rothman K, Greenland S, Lash T, L\u00f6nnroth K, Williams B, Stadlin S, Jaramillo E, Dye C, Shea B, Grimshaw J, Wells G, Boers M, Andersson N, Hamel C, Porter A, et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health. 2009;9:450.","journal-title":"BMC Public Health"},{"key":"3396_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5588\/ijtld.14.0516","volume":"19","author":"T Volkmann","year":"2015","unstructured":"Volkmann T, Moonan PK, Miramontes R, Oeltmann JE. Tuberculosis and excess alcohol use in the United States, 1997-2012. Int J Tuberc Lung Dis. 2015;19:111\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3396_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12879-015-0964-2","volume":"15","author":"G Theron","year":"2015","unstructured":"Theron G, Peter J, Zijenah L, Chanda D, Mangu C, Clowes P, Rachow A, Lesosky M, Hoelscher M, Pym A, Mwaba P, Mason P, Naidoo P, Pooran A, Sohn H, Pai M, Stein DJ, Dheda K. Psychological distress and its relationship with non-adherence to TB treatment: a multicentre study. BMC Infect Dis. 2015;15:253.","journal-title":"BMC Infect Dis"},{"key":"3396_CR5","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1513\/AnnalsATS.201312-447OC","volume":"11","author":"K Duraisamy","year":"2014","unstructured":"Duraisamy K, Mrithyunjayan S, Ghosh S, Nair SA, Balakrishnan S, Subramoniapillai J, Oeltmann JE, Moonan PK, Kumar AMV. Does alcohol consumption during multidrug-resistant tuberculosis treatment affect outcome?. A population-based study in Kerala, India. Ann Am Thorac Soc. 2014;11:712\u20138.","journal-title":"Ann Am Thorac Soc"},{"key":"3396_CR6","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1128\/IAI.72.5.2556-2563.2004","volume":"72","author":"CM Mason","year":"2004","unstructured":"Mason CM, Dobard E, Zhang P, Nelson S. Alcohol exacerbates murine pulmonary tuberculosis. Infect Immun. 2004;72:2556\u201363.","journal-title":"Infect Immun"},{"key":"3396_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1530-0277.2011.01624.x","volume":"36","author":"E Porretta","year":"2012","unstructured":"Porretta E, Happel KI, Teng XS, Ramsay A, Mason CM. The impact of alcohol on BCG-induced immunity against Mycobacterium tuberculosis. Alcohol Clin Exp Res. 2012;36:310\u20137.","journal-title":"Alcohol Clin Exp Res"},{"key":"3396_CR8","first-page":"1","volume":"2014","author":"Yan Liang","year":"2014","unstructured":"Liang Y, Harris FL, Brown LAS. Alcohol induced mitochondrial oxidative stress and alveolar macrophage dysfunction. Biomed Res Int 2014. 2014:371593.","journal-title":"BioMed Research International"},{"key":"3396_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imr.12274","volume":"264","author":"LD Jasenosky","year":"2015","unstructured":"Jasenosky LD, Scriba TJ, Hanekom WA, Goldfeld AE. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev. 2015;264:74\u201387.","journal-title":"Immunol Rev"},{"key":"3396_CR10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.35946\/arcr.v37.2.05","volume":"37","author":"SM Simet","year":"2015","unstructured":"Simet SM, Sisson JH. Alcohol\u2019s effects on lung health and immunity. Alcohol Res. 2015;37:199\u2013208.","journal-title":"Alcohol Res"},{"key":"3396_CR11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.pnpbp.2015.09.001","volume":"65","author":"T Barr","year":"2016","unstructured":"Barr T, Helms C, Grant K, Messaoudi I. Opposing effects of alcohol on the immune system. Prog Neuro-Psychopharmacol Biol Psychiatry. 2016;65:242\u201351.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"3396_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/cid\/cis353","volume":"55","author":"JG Pasipanodya","year":"2012","unstructured":"Pasipanodya JG, Srivastava S, Gumbo T. Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of Antituberculosis therapy. Clin Infect Dis An Off Publ Infect Dis Soc Am. 2012;55:169\u201377.","journal-title":"Clin Infect Dis An Off Publ Infect Dis Soc Am"},{"key":"3396_CR13","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1093\/infdis\/jir658","volume":"204","author":"S Srivastava","year":"2011","unstructured":"Srivastava S, Pasipanodya JG, Meek C, Leff R, Gumbo T. Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability. J Infect Dis. 2011;204:1951\u20139.","journal-title":"J Infect Dis"},{"key":"3396_CR14","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1086\/498024","volume":"41","author":"DC Perlman","year":"2005","unstructured":"Perlman DC, Segal Y, Rosenkranz S, Rainey PM, Remmel RP, Salomon N, Hafner R, Peloquin CA. AIDS Clinical Trials Group 309 team: the clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosis. Clin Infect Dis. 2005;41:1638\u201347.","journal-title":"Clin Infect Dis"},{"key":"3396_CR15","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1086\/429321","volume":"40","author":"M Weiner","year":"2005","unstructured":"Weiner M, Benator D, Burman W, Peloquin CA, Khan A, Vernon A, Jones B, Silva-Trigo C, Zhao Z, Hodge T. Tuberculosis trials consortium: association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis. Clin Infect Dis. 2005;40:1481\u201391.","journal-title":"Clin Infect Dis"},{"key":"3396_CR16","first-page":"1403","volume":"23","author":"R Ferrando","year":"1999","unstructured":"Ferrando R, Garrigues TM, Bermejo MV, Mart\u00edn-Algarra R, Merino V, Polache A. Effects of ethanol on intestinal absorption of drugs: in situ studies with ciprofloxacin analogs in acute and chronic alcohol-fed rats. Alcohol Clin Exp Res. 1999;23:1403\u20138.","journal-title":"Alcohol Clin Exp Res"},{"key":"3396_CR17","first-page":"326","volume":"21","author":"V Merino","year":"1997","unstructured":"Merino V, Martin-Algarra RV, Rocher A, Garrigues TM, Freixas J, Polache A. Effects of ethanol on intestinal absorption of drugs. I. in situ studies with ciprofloxacin analogs in normal and chronic alcohol-fed rats. Alcohol Clin Exp Res. 1997;21:326\u201333.","journal-title":"Alcohol Clin Exp Res"},{"key":"3396_CR18","unstructured":"Koriakin VA, Sokolova GB, Grinchar NA, Iurchenko LN. pharmacokinetics of isoniazid in patients with pulmonary tuberculosis and alcoholism. Probl Tuberk. 1986:43\u20136."},{"key":"3396_CR19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.15288\/qjsa.1964.25.541","volume":"25","author":"D Lester","year":"1964","unstructured":"Lester D. The acetylation of isoniazid in alcoholics. Q J Stud Alcohol. 1964;25:541\u20133.","journal-title":"Q J Stud Alcohol"},{"key":"3396_CR20","first-page":"1373","volume":"8","author":"JTR Wilcke","year":"2004","unstructured":"Wilcke JTR, D\u00f8ssing M, Angelo HR, Askgaard D, R\u00f8nn A, Christensen HR. Unchanged acetylation of isoniazid by alcohol intake. Int J Tuberc Lung Dis. 2004;8:1373\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3396_CR21","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1378\/chest.113.5.1178","volume":"113","author":"ME Kimerling","year":"1998","unstructured":"Kimerling ME, Phillips P, Patterson P, Hall M, Robinson CA, Dunlap NE. Low serum antimycobacterial drug levels in non-hiv-infected tuberculosis patients. Chest. 1998;113:1178\u201383.","journal-title":"Chest"},{"key":"3396_CR22","unstructured":"Statistics South Africa: Mortality and Causes of Death in South Africa, 2015: Findings from Death Notification. Pretoria; 2016;P0309.3:1\u2013127."},{"issue":"1","key":"3396_CR23","doi-asserted-by":"publisher","first-page":"1700216","DOI":"10.1183\/13993003.00216-2017","volume":"50","author":"Sameer Imtiaz","year":"2017","unstructured":"Imtiaz S, Shield KD, Roerecke M, Samokhvalov AV, L\u00f6nnroth K, Rehm J. Alcohol consumption as a risk factor for tuberculosis: meta-analyses and burden of disease. Eur Respir J. 2017;50.","journal-title":"European Respiratory Journal"},{"key":"3396_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.7196\/SAMJ.6249","volume":"103","author":"L Olivier","year":"2013","unstructured":"Olivier L, Urban M, Chersich M, Temmerman M, Viljoen D. Burden of fetal alcohol syndrome in a rural west coast area of South Africa. S Afr Med J. 2013;103:402\u20135.","journal-title":"S Afr Med J"},{"key":"3396_CR25","first-page":"65","volume":"11","author":"CDH Parry","year":"2012","unstructured":"Parry CDH, Gossage JP, Marais A-S, Barnard R, de Vries M, Blankenship J, Seedat S, May PA. Comparison of baseline drinking practices, knowledge, and attitudes of adults residing in communities taking part in the FAS prevention study in South Africa. Afr J Drug Alcohol Stud. 2012;11:65\u201376.","journal-title":"Afr J Drug Alcohol Stud"},{"key":"3396_CR26","doi-asserted-by":"publisher","first-page":"7406","DOI":"10.3390\/ijerph110707406","volume":"11","author":"JP Gossage","year":"2014","unstructured":"Gossage JP, Snell CL, Parry CDH, Marais A-S, Barnard R, de Vries M, Blankenship J, Seedat S, Hasken JM, May PA. Alcohol use, working conditions, job benefits, and the legacy of the \u201cDop\u201d system among farm workers in the Western Cape Province, South Africa: hope despite high levels of risky drinking. Int J Environ Res Public Health. 2014;11:7406\u201324.","journal-title":"Int J Environ Res Public Health"},{"key":"3396_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-4612-0357-5_3","volume-title":"Measuring alcohol consumption","author":"LC Sobell","year":"1992","unstructured":"Sobell LC, Sobell MB. Timeline follow-Back. In: Litten RZ, Allen J, editors. Measuring alcohol consumption. Totowa, NJ: Humana Press; 1992. p. 41\u201372."},{"key":"3396_CR28","volume-title":"The alcohol use disorders identification test","year":"2016","unstructured":"WHO | AUDIT, editor. The alcohol use disorders identification test. Geneva: World Health Organization; 2016."},{"key":"3396_CR29","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","volume":"86","author":"TF Heatherton","year":"1991","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Fagerstr\u00f6m KO. The Fagerstr\u00f6m test for nicotine dependence: a revision of the Fagerstr\u00f6m tolerance questionnaire. Br J Addict. 1991;86:1119\u201327.","journal-title":"Br J Addict"},{"key":"3396_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.addbeh.2011.07.030","volume":"37","author":"AC Voluse","year":"2012","unstructured":"Voluse AC, Gioia CJ, Sobell LC, Dum M, Sobell MB, Simco ER. Psychometric properties of the drug use disorders identification test (DUDIT) with substance abusers in outpatient and residential treatment. Addict Behav. 2012;37:36\u201341.","journal-title":"Addict Behav"},{"key":"3396_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/014662167700100306","volume":"1","author":"LS Radloff","year":"1977","unstructured":"Radloff LS. The CES-D scale. Appl Psychol Meas. 1977;1:385\u2013401.","journal-title":"Appl Psychol Meas"},{"key":"3396_CR32","unstructured":"Introducing a Simple Measure of Household Hunger for Cross-Cultural Use [ www.fao.org\/fileadmin\/user_upload\/wa_workshop\/docs\/HH_Hunger_Scale.pdf ]."},{"key":"3396_CR33","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/alcalc\/agu037","volume":"49","author":"J Jain","year":"2014","unstructured":"Jain J, Evans JL, Brice\u00f1o A, Page K, Hahn JA. Comparison of phosphatidylethanol results to self-reported alcohol consumption among young injection drug users. Alcohol Alcohol. 2014;49:520\u20134.","journal-title":"Alcohol Alcohol"},{"key":"3396_CR34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/cid\/cir406","volume":"53","author":"KR Jacobson","year":"2011","unstructured":"Jacobson KR, Theron D, Victor TC, Streicher EM, Warren RM, Murray MB. Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa. Clin Infect Dis. 2011;53:369\u201372.","journal-title":"Clin Infect Dis"},{"key":"3396_CR35","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5588\/ijtld.11.0116","volume":"16","author":"FK Mukinda","year":"2012","unstructured":"Mukinda FK, Theron D, van der Spuy GD, Jacobson KR, Roscher M, Streicher EM, Musekiwa A, Coetzee GJ, Victor TC, Marais BJ, Nachega JB, Warren RM, Schaaf HS. Rise in rifampicin-monoresistant tuberculosis in Western cape, South Africa. Int J Tuberc Lung Dis. 2012;16:196\u2013202.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3396_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1128\/AAC.03931-14","volume":"59","author":"E Chigutsa","year":"2015","unstructured":"Chigutsa E, Pasipanodya JG, Visser ME, van Helden PD, Smith PJ, Sirgel FA, Gumbo T, McIlleron H. Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in tuberculosis. Antimicrob Agents Chemother. 2015;59:38\u201345.","journal-title":"Antimicrob Agents Chemother"},{"key":"3396_CR37","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/EDE.0000000000000121","volume":"25","author":"TJ VanderWeele","year":"2014","unstructured":"VanderWeele TJ. A unification of mediation and interaction: a 4-way decomposition. Epidemiology. 2014;25:749\u201361.","journal-title":"Epidemiology"},{"key":"3396_CR38","first-page":"1","volume":"61","author":"CA Peloquin","year":"2017","unstructured":"Peloquin CA, Vel\u00e1squez GE, Lecca L, Calder\u00f3n RI, Coit J, Milstein M, Osso E, Jimenez J, Tintaya K, Sanchez Garavito E, Vargas Vasquez D, Mitnick CD, Davies G. Pharmacokinetic evidence from the HIRIF trial to support increased doses of rifampin for tuberculosis. Antimicrob Agents Chemother. 2017;61:1\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"3396_CR39","first-page":"139","volume":"12","author":"SK Katiyar","year":"2008","unstructured":"Katiyar SK, Bihari S, Prakash S, Mamtani M, Kulkarni H. A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2008;12:139\u201345.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3396_CR40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1164\/rccm.200901-0078OC","volume":"180","author":"SE Dorman","year":"2009","unstructured":"Dorman SE, Johnson JL, Goldberg S, Muzanye G, Padayatchi N, Bozeman L, Heilig CM, Bernardo J, Choudhri S, Grosset JH, Guy E, Guyadeen P, Leus MC, Maltas G, Menzies D, Nuermberger EL, Villarino M, Vernon A, Chaisson RE. Tuberculosis trials consortium: substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. Am J Respir Crit Care Med. 2009;180:273\u201380.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3396-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3396-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3396-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:24:13Z","timestamp":1760451853000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3396-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,29]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3396"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3396-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,29]]},"assertion":[{"value":"1 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol for this project is approved by four institutions\u2019 research ethics committees \/institutional review boards: South African Medical Research Council Human Research Ethics Committee, University of Cape Town Human Research Ethics Committee, Stellenbosch University Human Research Ethics Committee, and Boston University Institutional Review Board. Written, informed consent to participate in the study will be obtained from all participants if \u226518\u00a0years of age or written individual consent and separate parental consent if <\u200918\u00a0years.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"488"}}